Price T Rowe Associates Inc Royalty Pharma PLC Transaction History

Price T Rowe Associates Inc

  • $869 Billion
  • Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Royalty Pharma PLC stock. As of the latest transaction made, Price T Rowe Associates Inc holds 286,299 shares of RPRX stock, worth $6.95 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
286,299
Previous 270,452 5.86%
Holding current value
$6.95 Million
Previous $7.13 Million 13.57%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$25.63 - $29.27 $406,158 - $463,841
15,847 Added 5.86%
286,299 $8.1 Million
Q2 2024

Aug 14, 2024
BUY
$26.26 - $29.9 $229,039 - $260,787
8,722 Added 3.33%
270,452 $7.13 Million
Q1 2024

May 15, 2024
SELL
$27.46 - $31.33 $30.4 Million - $34.7 Million
-1,106,424 Reduced 80.87%
261,730 $7.95 Million
Q4 2023

Feb 14, 2024
SELL
$26.21 - $29.22 $16.3 Million - $18.2 Million
-622,848 Reduced 31.28%
1,368,154 $38.4 Million
Q3 2023

Nov 14, 2023
SELL
$26.26 - $31.38 $7.97 Million - $9.52 Million
-303,414 Reduced 13.22%
1,991,002 $54 Million
Q2 2023

Aug 14, 2023
SELL
$29.6 - $36.56 $5.37 Million - $6.64 Million
-181,531 Reduced 7.33%
2,294,416 $70.5 Million
Q1 2023

May 15, 2023
SELL
$32.77 - $39.4 $936,730 - $1.13 Million
-28,585 Reduced 1.14%
2,475,947 $89.2 Million
Q4 2022

Feb 14, 2023
BUY
$39.17 - $44.04 $6.33 Million - $7.12 Million
161,722 Added 6.9%
2,504,532 $99 Million
Q3 2022

Nov 14, 2022
SELL
$39.88 - $44.65 $388,112 - $434,533
-9,732 Reduced 0.41%
2,342,810 $94.1 Million
Q2 2022

Aug 15, 2022
BUY
$37.53 - $44.22 $3.43 Million - $4.04 Million
91,343 Added 4.04%
2,352,542 $98.9 Million
Q1 2022

May 16, 2022
SELL
$37.46 - $42.44 $612,845 - $694,318
-16,360 Reduced 0.72%
2,261,199 $88.1 Million
Q4 2021

Feb 14, 2022
BUY
$35.17 - $42.48 $2.84 Million - $3.43 Million
80,823 Added 3.68%
2,277,559 $90.8 Million
Q3 2021

Nov 15, 2021
SELL
$36.14 - $42.24 $112,648 - $131,662
-3,117 Reduced 0.14%
2,196,736 $79.4 Million
Q2 2021

Aug 16, 2021
SELL
$39.85 - $46.63 $6.15 Million - $7.2 Million
-154,365 Reduced 6.56%
2,199,853 $90.2 Million
Q1 2021

May 17, 2021
SELL
$42.34 - $52.82 $36.2 Million - $45.2 Million
-854,937 Reduced 26.64%
2,354,218 $103 Million
Q4 2020

Feb 16, 2021
BUY
$36.12 - $50.05 $116 Million - $161 Million
3,209,155 New
3,209,155 $161 Million

Others Institutions Holding RPRX

# of Institutions
413
Shares Held
283M
Call Options Held
578K
Put Options Held
47.5K
View Full List

About Royalty Pharma plc

RPRX Quotes by TradingView
  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $10.6B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email